(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1352263 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ABL2 mRNA CTD PMID:22079256 1,1-dichloroethene increases expression ISO RGD:10053 6480464 vinylidene chloride results in increased expression of ABL2 mRNA CTD PMID:26682919 17beta-estradiol multiple interactions ISO RGD:1352263 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ABL2 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:1352263 6480464 Estradiol results in increased expression of ABL2 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1352263 6480464 Tetrachlorodibenzodioxin results in increased expression of ABL2 mRNA CTD PMID:21296121 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1352263 6480464 Tetrachlorodibenzodioxin affects the expression of ABL2 mRNA CTD PMID:22298810 2-hydroxypropanoic acid increases expression ISO RGD:1352263 6480464 Lactic Acid results in increased expression of ABL2 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1352263 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA CTD PMID:28628672 acrolein multiple interactions ISO RGD:1352263 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ABL2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ABL2 mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO RGD:10053 6480464 Aflatoxin B1 results in increased expression of ABL2 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1352263 6480464 Aflatoxin B1 results in increased methylation of ABL2 intron CTD PMID:30157460 alpha-pinene multiple interactions ISO RGD:1352263 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ABL2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ABL2 mRNA CTD PMID:32699268 aristolochic acid increases expression ISO RGD:1352263 6480464 aristolochic acid I results in increased expression of ABL2 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1352263 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABL2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1352263 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABL2 mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO RGD:1352263 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ABL2 mRNA] CTD PMID:32406909 benzo[a]pyrene decreases methylation ISO RGD:1352263 6480464 Benzo(a)pyrene results in decreased methylation of ABL2 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1352263 6480464 Benzo(a)pyrene affects the methylation of ABL2 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1352263 6480464 Benzo(a)pyrene results in increased methylation of ABL2 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1352263 6480464 7 more ... CTD PMID:20018196 benzo[e]pyrene increases methylation ISO RGD:1352263 6480464 benzo(e)pyrene results in increased methylation of ABL2 intron CTD PMID:30157460 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ABL2 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ABL2 mRNA CTD PMID:34947998 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ABL2 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol F multiple interactions ISO RGD:1352263 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA CTD PMID:28628672 boron nitride increases expression ISO RGD:1352263 6480464 boron nitride results in increased expression of ABL2 mRNA CTD PMID:30644070 butanal increases expression ISO RGD:1352263 6480464 butyraldehyde results in increased expression of ABL2 mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of ABL2 mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:1352263 6480464 Cadmium results in increased expression of ABL2 mRNA CTD PMID:21120746 cadmium sulfate increases expression ISO RGD:1352263 6480464 cadmium sulfate results in increased expression of ABL2 mRNA CTD PMID:12064557 , PMID:14676411 cannabidiol multiple interactions ISO RGD:1352263 6480464 [Dronabinol co-treated with Cannabidiol] results in increased expression of ABL2 mRNA CTD PMID:26504004 carbamazepine affects expression ISO RGD:1352263 6480464 Carbamazepine affects the expression of ABL2 mRNA CTD PMID:24752500 cisplatin multiple interactions ISO RGD:1352263 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ABL2 mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:1352263 6480464 [NSC 689534 binds to Copper] which results in increased expression of ABL2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1352263 6480464 [NSC 689534 binds to Copper] which results in increased expression of ABL2 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:1352263 6480464 Copper Sulfate results in increased expression of ABL2 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1352263 6480464 Asbestos, Crocidolite results in increased expression of ABL2 mRNA CTD PMID:18687144 , PMID:25351596 crocidolite asbestos affects expression ISO RGD:1352263 6480464 Asbestos, Crocidolite affects the expression of ABL2 mRNA CTD PMID:25757056 cyclosporin A increases expression ISO RGD:1352263 6480464 Cyclosporine results in increased expression of ABL2 mRNA CTD PMID:20106945 dexamethasone multiple interactions ISO RGD:1352263 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA CTD PMID:28628672 diclofenac affects expression ISO RGD:1352263 6480464 Diclofenac affects the expression of ABL2 mRNA CTD PMID:24752500 dopamine decreases expression EXP 6480464 Dopamine results in decreased expression of ABL2 mRNA CTD PMID:21983523 dorsomorphin multiple interactions ISO RGD:1352263 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1352263 6480464 Doxorubicin results in decreased expression of ABL2 mRNA CTD PMID:29803840 ethanol affects splicing ISO RGD:10053 6480464 Ethanol affects the splicing of ABL2 mRNA CTD PMID:30319688 fenoldopam increases expression EXP 6480464 Fenoldopam results in increased expression of ABL2 mRNA CTD PMID:21983523 fluoranthene multiple interactions ISO RGD:10053 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of ABL2 mRNA CTD PMID:28329830 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ABL2 mRNA CTD PMID:33387578 hydrogen peroxide multiple interactions ISO RGD:10053 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 indometacin multiple interactions ISO RGD:1352263 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA CTD PMID:28628672 lead(0) decreases expression ISO RGD:1352263 6480464 Lead results in decreased expression of ABL2 mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:1352263 6480464 Lead results in decreased expression of ABL2 mRNA CTD PMID:19921347 lipopolysaccharide multiple interactions ISO RGD:10053 6480464 [Lipopolysaccharides co-treated with IL4] results in increased expression of ABL2 mRNA, Lipopolysaccharides affects the reaction [IL4 protein results in increased expression of ABL2 mRNA] CTD PMID:22024136 lipopolysaccharide decreases expression ISO RGD:10053 6480464 Lipopolysaccharides results in decreased expression of ABL2 mRNA CTD PMID:22024136 methapyrilene increases methylation ISO RGD:1352263 6480464 Methapyrilene results in increased methylation of ABL2 intron CTD PMID:30157460 methylisothiazolinone increases expression ISO RGD:1352263 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of ABL2 mRNA CTD PMID:31629900 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of ABL2 gene CTD PMID:33148267 nickel atom increases expression ISO RGD:1352263 6480464 Nickel results in increased expression of ABL2 mRNA CTD PMID:24768652 , PMID:25583101 ozone multiple interactions ISO RGD:1352263 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ABL2 mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO RGD:1352263 6480464 Acetaminophen results in increased expression of ABL2 mRNA CTD PMID:29067470 perfluorononanoic acid increases expression ISO RGD:1352263 6480464 perfluoro-n-nonanoic acid results in increased expression of ABL2 mRNA CTD PMID:32588087 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of ABL2 gene CTD PMID:33148267 phenobarbital affects expression ISO RGD:1352263 6480464 Phenobarbital affects the expression of ABL2 mRNA CTD PMID:19159669 phenylmercury acetate multiple interactions ISO RGD:1352263 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA CTD PMID:27188386 ponatinib decreases activity ISO RGD:1352263 6480464 ponatinib results in decreased activity of ABL2 protein CTD PMID:19878872 potassium chromate multiple interactions ISO RGD:1352263 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ABL2 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1352263 6480464 potassium chromate(VI) results in increased expression of ABL2 mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO RGD:10053 6480464 Potassium Dichromate results in decreased expression of ABL2 mRNA CTD PMID:23608068 rac-lactic acid increases expression ISO RGD:1352263 6480464 Lactic Acid results in increased expression of ABL2 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1352263 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1352263 6480464 Silicon Dioxide analog results in increased expression of ABL2 mRNA, Silicon Dioxide results in increased expression of ABL2 mRNA CTD PMID:25351596 , PMID:25895662 sodium arsenate decreases expression ISO RGD:10053 6480464 sodium arsenate results in decreased expression of ABL2 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:1352263 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABL2 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1352263 6480464 sodium arsenite results in increased expression of ABL2 mRNA CTD PMID:12760830 sodium arsenite decreases expression ISO RGD:1352263 6480464 sodium arsenite results in decreased expression of ABL2 mRNA CTD PMID:29301061 taurine increases expression ISO RGD:1352263 6480464 Taurine results in increased expression of ABL2 mRNA CTD PMID:16579726 testosterone decreases expression ISO RGD:1352263 6480464 Testosterone results in decreased expression of ABL2 mRNA CTD PMID:33359661 theophylline decreases expression ISO RGD:1352263 6480464 Theophylline results in decreased expression of ABL2 mRNA CTD PMID:16083514 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ABL2 mRNA CTD PMID:34492290 tungsten decreases expression ISO RGD:10053 6480464 Tungsten results in decreased expression of ABL2 mRNA CTD PMID:30912803 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of ABL2 mRNA CTD PMID:29427782 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of ABL2 mRNA CTD PMID:29427782 xylitol increases expression ISO RGD:1352263 6480464 Xylitol results in increased expression of ABL2 mRNA CTD PMID:32275922